Experimental anti-cholesterol drug shows promise

March 15, 2015 6:40 PM

4 0

People taking an experimental drug called Repatha (evolocumab) for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins, researchers said Sunday.

The findings were based on 4,465 patients who were studied for one year after completing an earlier phase of the drug's safety and efficacy testing.

Also read: RBS Fails Toughest-Ever BOE Stress Test, Boosts Capital Plan

Read more

To category page

Loading...